Sun-Hee Kim

Prof. Dr. Sun-Hee Kim

Department of Laboratory Medicine & Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2014 in International Journal of Laboratory Hematology
Verified
Journal Article
Closed access
PDF file
JSJ. Y. Seo
J. Y. Seo
SLSeung-Tae Lee
Seung-Tae Lee
SKSun-Hee Kim
Sun-Hee Kim

11 June 2010 in International Journal of Hematology
Verified
Journal Article
Closed access
PDF file
T(The Korean Multiple Myeloma Working Party (Kmmwp)
The Korean Multiple Myeloma Working Party (Kmmwp)
JLJae Hoon Lee
Jae Hoon Lee
DLDong Soon Lee
Dong Soon Lee
JLJe-Jung Lee
Je-Jung Lee
YCYoon Hwan Chang
Yoon Hwan Chang
KCKyung Sam Cho
Kyung Sam Cho

31 August 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
BKBorahm Kim
Borahm Kim
WYWoobin Yun
Woobin Yun
SLSeung-Tae Lee
Seung-Tae Lee
JCJong Rok Choi
Jong Rok Choi
KYKeon Hee Yoo
Keon Hee Yoo
SKSun-Hee Kim
Sun-Hee Kim
Acute myeloid leukemia (AML) is one of the most common types of leukemia. With the recent advances in sequencing technology and the growing body of knowledge on the genetics of AML, there is increasing concern about cancer predisposing germline mutations as well as somatic mutations. As familial cases sharing germline mutations are constantly reported, germline predisposition gene mutations in patients with AML are gaining attention. We performed genomic sequencing of Korean patients diagnosed with AML to identify the prevalence and characteristics of germline predisposition mutations. Among 180 patients, germline predisposition mutations were identified in 13 patients (13/180, 7.2%, eight adults and five children). Germline mutations of BLM, BRCA1, BRCA2, CTC1, DDX41, ERCC4, ERCC6, FANCI, FANCM, PALB2, and SBDS were identified. Most of the mutations are in genes involved in DNA repair and genomic stability maintenance. Patients harboring germline mutations tended to have earlier onset of AML (p = 0.005), however, the presence of germline mutations did not showed significant association with other clinical characteristics or treatment outcome. Since each mutation was rare, further study with a larger number of cases would be needed to establish the effect of the mutations.

10 December 2011 in Journal of Clinical Oncology
Verified
Journal Article
Open access
JYJun Ho Yi
Jun Ho Yi
Jungwon HuhJungwon Huh
Jungwon Huh
HKHee-Jin Kim
Hee-Jin Kim
SKSun-Hee Kim
Sun-Hee Kim
HKHyeoung-Joon Kim
Hyeoung-Joon Kim
DKDong Hwan Kim
Dong Hwan Kim
Purpose: This study attempted to analyze the prognostic role of single nucleotide polymorphism array (SNP-A) –based karyotying in 133 patients with acute myeloid leukemia with normal karyotype (AML-NK), which presents with diverse clinical outcomes, thus requiring further stratification of patient subgroups according to their prognoses.Patients and Methods: A total of 133 patients with AML-NK confirmed by metaphase cytogenetics (MC) and fluorescent in situ hybridization analysis were included in this study. Analysis by Genome-Wide Human SNP 6.0 Array was performed by using DNAs derived from marrow samples at diagnosis.Results: Forty-three patients (32.3%) had at least one abnormal SNP lesion that was not detected by MC. One hundred thirteen abnormal SNP lesions included 55 losses, 23 gains, and 35 copy-neutral losses of heterozygosity. Multivariate analyses showed that detection of abnormal SNP lesions by SNP-A karyotyping results in an unfavorable prognostic value for overall survival (hazard ratio [HR], 2.69; 95% CI, 1.50 to 4.82; P = .001); other significant prognostic factors included secondary AML (HR, 5.55; 95% CI, 1.80 to 17.14; P = .003), presence of the FLT3 mutation (HR, 3.17; 95% CI, 1.71 to 5.87; P < .001), and age (HR, 1.03; 95% CI, 1.01 to 1.05; P = .020).Conclusion: Our data demonstrated that abnormal SNP lesions detected by SNP-A karyotyping might indicate an adverse prognosis in patients with AML-NK, thus requiring a more sophisticated treatment strategy for improvement of treatment outcomes.

23 June 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
SSSang-Yong Shin
Sang-Yong Shin
SLSeung-Tae Lee
Seung-Tae Lee
HKHee-Jin Kim
Hee-Jin Kim
ECEun Hae Cho
Eun Hae Cho
JKJong-Won Kim
Jong-Won Kim
SKSun-Hee Kim
Sun-Hee Kim
Mutation profiling of 19 candidate genes in acute myeloid leukemia suggests significance of DNMT3A mutations

1 March 2015 in Annals of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
BKBorahm Kim
Borahm Kim
SLSeung-Tae Lee
Seung-Tae Lee
HKHee-Jin Kim
Hee-Jin Kim
SKSun-Hee Kim
Sun-Hee Kim
Kim B, et al. Ann Lab Med. 2015 Mar;35(2):187-193. http://dx.doi.org/10.3343/alm.2015.35.2.187